Haleon (XTER:H6D0) Short-Term Capital Lease Obligation : €0 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Haleon Short-Term Capital Lease Obligation?

Haleon's Short-Term Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0 Mil.

Haleon's quarterly Short-Term Capital Lease Obligation increased from Sep. 2023 (€0 Mil) to Dec. 2023 (€56 Mil) but then declined from Dec. 2023 (€56 Mil) to Mar. 2024 (€0 Mil).

Haleon's annual Short-Term Capital Lease Obligation increased from Dec. 2021 (€35 Mil) to Dec. 2022 (€51 Mil) and increased from Dec. 2022 (€51 Mil) to Dec. 2023 (€56 Mil).

Haleon Short-Term Capital Lease Obligation Historical Data

The historical data trend for Haleon's Short-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Haleon Short-Term Capital Lease Obligation Chart

Haleon Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Capital Lease Obligation

47.18

37.57

35.31

50.59

55.72

Haleon Quarterly Data
	Dec19	Dec20	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Capital Lease Obligation	Get a 7-Day Free Trial									-	47.78	-	55.72	-

Haleon Short-Term Capital Lease Obligation Explanation

Short-Term Capital Lease Obligation represents the total amount of Long-Term Capital Lease Obligation that must be paid within the next accounting period. Capital lease obligations are contractual obligations that arise from obtaining the use of property or equipment via a capital lease contract.

Haleon Short-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of Haleon's Short-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.

Haleon (XTER:H6D0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Haleon PLC (XTER:H6D0) » Definitions » Short-Term Capital Lease Obligation

Comparable Companies

Traded in Other Exchanges

HLNCF:USA HLN:USA HLN1:Mexico HLNl:UK HLN:UK

Address

The Heights, Building 5, First Floor, Surrey, Weybridge, GBR, KT13 0NY

Website

https://www.haleon.com

Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.

Haleon (XTER:H6D0) Headlines

No Headlines